Neglected diseases of poverty
2 questions in the Atlas. None open right now. Know something we don't? Send us a problem.
In this field
2 questions, strongest case first
- Finding the villages where ivermectin treatment for river blindness is safe to give, in areas where loiasis is also commonRejected on prior art and tractability: the Lancaster/Manchester group (Johnson, Giorgi, Diggle) already models where ivermectin is safe in Loa co-endemic areas, and its 2026 Nigeria repository does the scout's exact extreme-value, satellite-covariate, held-out model; the public intensity data are one 92-village Gabon subset, so progress in the hypoendemic areas that matter needs new LoaScope surveys and custodian data, not compute.
- Where strongyloidiasis is common enough that ivermectin should be added to school dewormingParked: the gap is real (WHO's 2024 guideline needs prevalence data that are scarce, and no mass programmes exist), but most published surveys used stool tests so insensitive that, once corrected, they straddle WHO's 10% true-prevalence line; the one dense national dataset (Cambodia) showed little gain from spatial modelling; and funded groups (Stanford Cote d'Ivoire, Western Pacific 1 km map) are close.
Other fields
- Climate and parametric insurance4
- Rare pediatric cancer4
- Disaster early warning3
- Maternal and newborn health in low-resource settings3
- Neglected diseases caught from soil and food3
- Soil, groundwater and fisheries3
- Water and sanitation in poor regions3
- Lead and toxic metal exposure2
- Math with climate significance2
- Radiation oncology2
- Africa food security1
- Clean energy1
- Humanitarian food assistance targeting1
- Lightning deaths1
- Manufacturing1
- Weather observation networks in Africa1